Advertisement
Advertisement

PAHC

PAHC logo

Phibro Animal Health Corporation Class A

31.69
USD
Sponsored
-0.14
-0.44%
Jun 26, 15:59 UTC -4
Closed
exchange

After-Market

31.69

0.00
0.00%

PAHC Earnings Reports

Positive Surprise Ratio

PAHC beat 26 of 41 last estimates.

63%

Next Report

Date of Next Report
Aug 25, 2026
Estimate for Q4 26 (Revenue/ EPS)
$388.87M
/
$0.72
Implied change from Q3 26 (Revenue/ EPS)
+1.40%
/
-5.26%
Implied change from Q4 25 (Revenue/ EPS)
+2.69%
/
+28.57%

Phibro Animal Health Corporation Class A earnings per share and revenue

On May 06, 2026, PAHC reported earnings of 0.76 USD per share (EPS) for Q3 26, beating the estimate of 0.72 USD, resulting in a 4.50% surprise. Revenue reached 383.50 million, compared to an expected 374.36 million, with a 2.44% difference. The market reacted with a -26.22% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.72 USD, with revenue projected to reach 388.87 million USD, implying an decrease of -5.26% EPS, and increase of 1.40% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Canopy Growth Corporation Common Shares
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.09
Actual
-$0.40
Surprise
-309.74%
logo
High Tide Inc. Common Shares
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.02
Actual
$0.01
Surprise
+135.97%
FAQ
For Q3 2026, Phibro Animal Health Corporation Class A reported EPS of $0.76, beating estimates by 4.5%, and revenue of $383.50M, 2.44% above expectations.
The stock price moved down -26.22%, changed from $58.50 before the earnings release to $43.16 the day after.
The next earning report is scheduled for Aug 25, 2026.
Based on -- analysts, Phibro Animal Health Corporation Class A is expected to report EPS of $0.72 and revenue of $388.87M for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement